Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest Articles
Jabbour E et al. - The correlations with overall survival were not seen for advanced phases. Mutation scoring can predict outcome in CML-CP with imatinib failure treated with second generation TKIs and can help in therapy selection. More complex prognostic models will be required for advanced stages of disease.
Related Articles
Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who develop pleural effusion
Cancer, 11/25/09
Relevance Score: 83%
Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response, a study of the GIMEMA CML WP
Blood, 10/09/09
Relevance Score: 82%
Epidemiological study on survival of chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL) patients with BCR-ABL T315I mutation
Blood, 11/06/09
Relevance Score: 81%
SUZ12 is a candidate target of the non-canonical WNT pathway in the progression of chronic myeloid leukemia
Genes, Chromosomes and Cancer, 10/28/09
Relevance Score: 81%
Dasatinib treatment of chronic phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations
Blood, 10/02/09
Relevance Score: 81%
Today in Myeloproliferative Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes
Leukemia Research, 03/12/10
FISH and SNP-A karyotyping in myelodysplastic syndromes: Improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q)
Leukemia Research, 03/11/10
Non-myeloablative conditioning and allogeneic transplantation for multiple myeloma
American Journal of Hematology, 03/10/10
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Collateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancer : The Lancet Oncology
The Lancet Oncology - Online First, 03/15/10
Pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell support
Annals of Oncology, 03/15/10
Economic evaluation of docetaxel–gemcitabine versus vinorelbine–cisplatin combination as front-line treatment of patients with advanced/metastatic non-small-cell lung cancer in Greece: a cost-minimization analysis
Annals of Oncology, 03/15/10
Article Search
Sponsor
Sponsor